Health officials declare all recent STV arrivals Covid-free – so far

Pfizer is claiming that it’s current Covid-19 vaccine candidate “may be 90% effective” at preventing infection from the coronavirus. The pharmaceutical company says later this month they could be ready to file an ’emergency use’ application with US regulators.

US-based Pfizer and its German partner BioNTech are claiming that their vaccine against Covid-19 was “strongly effective” and has “exceeded expectations” with results that are likely to be met with cautious excitement amidst the global pandemic.

The vaccine trial is the first in the US to generate late-stage data. During yesterday’s announcement the companies claimed that early analysis of the results indicated that individuals who received 2 injections of the vaccine, 3 weeks apart, experienced more than 90% fewer cases of symptomatic Covid-19 than those on the placebo. Phase 3 study is ongoing and new…